These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 19035835)
1. Antiangiogenic forms of antithrombin specifically bind to the anticoagulant heparin sequence. Schedin-Weiss S; Richard B; Hjelm R; Olson ST Biochemistry; 2008 Dec; 47(51):13610-9. PubMed ID: 19035835 [TBL] [Abstract][Full Text] [Related]
2. Kinetic evidence that allosteric activation of antithrombin by heparin is mediated by two sequential conformational changes. Schedin-Weiss S; Richard B; Olson ST Arch Biochem Biophys; 2010 Dec; 504(2):169-76. PubMed ID: 20816747 [TBL] [Abstract][Full Text] [Related]
3. Antiangiogenic antithrombin blocks the heparan sulfate-dependent binding of proangiogenic growth factors to their endothelial cell receptors: evidence for differential binding of antiangiogenic and anticoagulant forms of antithrombin to proangiogenic heparan sulfate domains. Zhang W; Swanson R; Xiong Y; Richard B; Olson ST J Biol Chem; 2006 Dec; 281(49):37302-10. PubMed ID: 17040907 [TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic function of antithrombin is dependent on its conformational variation: implication for other serpins. Azhar A; Singh P; Rashid Q; Naseem A; Khan MS; Jairajpuri MA Protein Pept Lett; 2013 Apr; 20(4):403-11. PubMed ID: 23016581 [TBL] [Abstract][Full Text] [Related]
5. The signature 3-O-sulfo group of the anticoagulant heparin sequence is critical for heparin binding to antithrombin but is not required for allosteric activation. Richard B; Swanson R; Olson ST J Biol Chem; 2009 Oct; 284(40):27054-64. PubMed ID: 19661062 [TBL] [Abstract][Full Text] [Related]
6. Roles of N-terminal region residues Lys11, Arg13, and Arg24 of antithrombin in heparin recognition and in promotion and stabilization of the heparin-induced conformational change. Schedin-Weiss S; Desai UR; Bock SC; Olson ST; Björk I Biochemistry; 2004 Jan; 43(3):675-83. PubMed ID: 14730971 [TBL] [Abstract][Full Text] [Related]
7. Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement. Olson ST; Björk I; Sheffer R; Craig PA; Shore JD; Choay J J Biol Chem; 1992 Jun; 267(18):12528-38. PubMed ID: 1618758 [TBL] [Abstract][Full Text] [Related]
8. The region of antithrombin interacting with full-length heparin chains outside the high-affinity pentasaccharide sequence extends to Lys136 but not to Lys139. Arocas V; Turk B; Bock SC; Olson ST; Björk I Biochemistry; 2000 Jul; 39(29):8512-8. PubMed ID: 10913257 [TBL] [Abstract][Full Text] [Related]
9. Crystal structure of antithrombin in a heparin-bound intermediate state. Johnson DJ; Huntington JA Biochemistry; 2003 Jul; 42(29):8712-9. PubMed ID: 12873131 [TBL] [Abstract][Full Text] [Related]
10. The heparin-binding site of antithrombin is crucial for antiangiogenic activity. Zhang W; Swanson R; Izaguirre G; Xiong Y; Lau LF; Olson ST Blood; 2005 Sep; 106(5):1621-8. PubMed ID: 15905187 [TBL] [Abstract][Full Text] [Related]
11. Mechanism of heparin activation of antithrombin. Role of individual residues of the pentasaccharide activating sequence in the recognition of native and activated states of antithrombin. Desai UR; Petitou M; Björk I; Olson ST J Biol Chem; 1998 Mar; 273(13):7478-87. PubMed ID: 9516447 [TBL] [Abstract][Full Text] [Related]
12. The role of Arg46 and Arg47 of antithrombin in heparin binding. Arocas V; Bock SC; Olson ST; Björk I Biochemistry; 1999 Aug; 38(31):10196-204. PubMed ID: 10433728 [TBL] [Abstract][Full Text] [Related]
13. Cooperative Interactions of Three Hotspot Heparin Binding Residues Are Critical for Allosteric Activation of Antithrombin by Heparin. Richard B; Swanson R; Izaguirre G; Olson ST Biochemistry; 2018 Apr; 57(15):2211-2226. PubMed ID: 29561141 [TBL] [Abstract][Full Text] [Related]
14. Mechanism of heparin activation of antithrombin: evidence for an induced-fit model of allosteric activation involving two interaction subsites. Desai UR; Petitou M; Björk I; Olson ST Biochemistry; 1998 Sep; 37(37):13033-41. PubMed ID: 9737884 [TBL] [Abstract][Full Text] [Related]
15. Characterization of the conformational alterations, reduced anticoagulant activity, and enhanced antiangiogenic activity of prelatent antithrombin. Richard B; Swanson R; Schedin-Weiss S; Ramirez B; Izaguirre G; Gettins PG; Olson ST J Biol Chem; 2008 May; 283(21):14417-29. PubMed ID: 18375953 [TBL] [Abstract][Full Text] [Related]
16. Sulfamate proton solvent exchange in heparin oligosaccharides: evidence for a persistent hydrogen bond in the antithrombin-binding pentasaccharide Arixtra. Langeslay DJ; Young RP; Beni S; Beecher CN; Mueller LJ; Larive CK Glycobiology; 2012 Sep; 22(9):1173-82. PubMed ID: 22593556 [TBL] [Abstract][Full Text] [Related]
17. Mechanism by which exosites promote the inhibition of blood coagulation proteases by heparin-activated antithrombin. Izaguirre G; Swanson R; Raja SM; Rezaie AR; Olson ST J Biol Chem; 2007 Nov; 282(46):33609-33622. PubMed ID: 17875649 [TBL] [Abstract][Full Text] [Related]
18. Interaction of designed sulfated flavanoids with antithrombin: lessons on the design of organic activators. Gunnarsson GT; Desai UR J Med Chem; 2002 Sep; 45(20):4460-70. PubMed ID: 12238925 [TBL] [Abstract][Full Text] [Related]
19. An unusual antithrombin-binding heparin octasaccharide with an additional 3-O-sulfated glucosamine in the active pentasaccharide sequence. Guerrini M; Elli S; Mourier P; Rudd TR; Gaudesi D; Casu B; Boudier C; Torri G; Viskov C Biochem J; 2013 Jan; 449(2):343-51. PubMed ID: 23083208 [TBL] [Abstract][Full Text] [Related]
20. The anticoagulant activation of antithrombin by heparin. Jin L; Abrahams JP; Skinner R; Petitou M; Pike RN; Carrell RW Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14683-8. PubMed ID: 9405673 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]